These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. A longitudinal study of cerebrospinal fluid beta-endorphin-like immunoreactivity in delirium: changes at the acute stage and at one-year follow-up. Koponen H; Riekkinen J Acta Psychiatr Scand; 1990 Oct; 82(4):323-6. PubMed ID: 2260489 [TBL] [Abstract][Full Text] [Related]
4. Beta-endorphin-like immunoreactivity in CSF of patients with acute head injury. A clinical report of 36 cases. Jiang JY; Zhu C; Chen CC; Wang CH; Zhu YX; Lin BC Chin Med J (Engl); 1989 Feb; 102(2):137-9. PubMed ID: 2528443 [TBL] [Abstract][Full Text] [Related]
5. beta-Endorphin-like immunoreactivity in cerebrospinal fluid of patients with Alzheimer's disease and Parkinson's disease. Jolkkonen JT; Soininen HS; Riekkinen PJ J Neurol Sci; 1987 Feb; 77(2-3):153-9. PubMed ID: 2950209 [TBL] [Abstract][Full Text] [Related]
6. A long-term follow-up study of cerebrospinal fluid somatostatin in delirium. Koponen HJ; Leinonen E; Lepola U; Riekkinen PJ Acta Psychiatr Scand; 1994 May; 89(5):329-34. PubMed ID: 7915078 [TBL] [Abstract][Full Text] [Related]
7. A long-term follow-up study of cerebrospinal fluid 5-hydroxyindoleacetic acid in delirium. Koponen HJ; Lepola U; Leinonen E Eur Arch Psychiatry Clin Neurosci; 1994; 244(3):131-4. PubMed ID: 7528542 [TBL] [Abstract][Full Text] [Related]
8. Elevated CSF beta-endorphin immunoreactivity in Rett's syndrome: report of 158 cases and comparison with leukemic children. Myer EC; Tripathi HL; Brase DA; Dewey WL Neurology; 1992 Feb; 42(2):357-60. PubMed ID: 1736165 [TBL] [Abstract][Full Text] [Related]
9. Cerebrospinal fluid somatostatin in delirium. II. Changes at the acute stage and at one year follow-up. Koponen H; Reinikainen K; Riekkinen PJ Psychol Med; 1990 Aug; 20(3):501-5. PubMed ID: 1978369 [TBL] [Abstract][Full Text] [Related]
10. A systematic literature review of cerebrospinal fluid biomarkers in delirium. Hall RJ; Shenkin SD; Maclullich AM Dement Geriatr Cogn Disord; 2011; 32(2):79-93. PubMed ID: 21876357 [TBL] [Abstract][Full Text] [Related]
11. Effects of pituitary beta-endorphin secretagogues on the concentration of beta-endorphin in rat cerebrospinal fluid: evidence for a role of vasopressin in the regulation of brain beta-endorphin release. Barna I; Sweep CG; Veldhuis HD; Wiegant VM; De Wied D Neuroendocrinology; 1990 Jan; 51(1):104-10. PubMed ID: 2137562 [TBL] [Abstract][Full Text] [Related]
12. Radioimmunoassay of beta-endorphin in ventricular and lumbar cerebrospinal fluid. Bach FW; Schmidt JF; Faber T Clin Chem; 1992 Jun; 38(6):847-52. PubMed ID: 1597010 [TBL] [Abstract][Full Text] [Related]
13. Increased cerebrospinal fluid beta-endorphin immunoreactivity in infants with apnea and in siblings of victims of sudden infant death syndrome. Myer EC; Morris DL; Adams ML; Brase DA; Dewey WL J Pediatr; 1987 Nov; 111(5):660-6. PubMed ID: 2959762 [TBL] [Abstract][Full Text] [Related]
14. Release of beta-endorphin and methionine-enkephalin into cerebrospinal fluid during deep brain stimulation for chronic pain. Effects of stimulation locus and site of sampling. Young RF; Bach FW; Van Norman AS; Yaksh TL J Neurosurg; 1993 Dec; 79(6):816-25. PubMed ID: 8246048 [TBL] [Abstract][Full Text] [Related]
15. Beta-endorphin-like immunoreactivity increases in cerebrospinal fluid of acute head-injured patients. Yao JJ; Cheng Z; Ce CC; Hai WC; Xiang ZY; Cheng LB Neuropeptides; 1988 Oct; 12(3):177-9. PubMed ID: 2977215 [TBL] [Abstract][Full Text] [Related]
16. Decreased level of beta-endorphin-like immunoreactivity in cerebrospinal fluid of patients with senile dementia of Alzheimer type. Kaiya H; Tanaka T; Takeuchi K; Morita K; Adachi S; Shirakawa H; Ueki H; Namba M Life Sci; 1983 Sep; 33(11):1039-43. PubMed ID: 6310293 [TBL] [Abstract][Full Text] [Related]